» Articles » PMID: 22789544

Innate Neural Stem Cell Heterogeneity Determines the Patterning of Glioma Formation in Children

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2012 Jul 14
PMID 22789544
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The concept that gliomas comprise a heterogeneous group of diseases distinguished by their developmental origin raises the intriguing possibility that neural stem cells (NSCs) from different germinal zones have differential capacities to respond to glioma-causing genetic changes. We demonstrate that lateral ventricle subventricular zone NSCs are molecularly and functionally distinct from those of the third ventricle. Consistent with a unique origin for pediatric low-grade glioma, third ventricle, but not lateral ventricle, NSCs hyperproliferate in response to mutations characteristic of childhood glioma. Finally, we demonstrate that pediatric optic gliomas in Nf1 genetically engineered mice arise from the third ventricle. Collectively, these observations establish the importance of innate brain region NSC heterogeneity in the patterning of gliomagenesis in children and adults.

Citing Articles

Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of neurofibromatosis type 1 optic pathway glioma.

Chan A, Zhang K, Martin G, Bano S, Chatterjee J, Mahto S Neuro Oncol. 2024; 26(12):2339-2351.

PMID: 39023130 PMC: 11630557. DOI: 10.1093/neuonc/noae136.


Single cell spatial biology over developmental time can decipher pediatric brain pathologies.

Nussinov R, Yavuz B, Jang H Neurobiol Dis. 2024; 199:106597.

PMID: 38992777 PMC: 11286356. DOI: 10.1016/j.nbd.2024.106597.


Single-cell transcriptomic analysis identifies downregulated phosphodiesterase 8B as a novel oncogene in IDH-mutant glioma.

He Z, Peng Y, Wang D, Yang C, Zhou C, Gong B Front Immunol. 2024; 15:1427200.

PMID: 38989284 PMC: 11233524. DOI: 10.3389/fimmu.2024.1427200.


An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.

Chen Y, Yu J, Ge S, Jia R, Song X, Wang Y Invest Ophthalmol Vis Sci. 2024; 65(6):8.

PMID: 38837168 PMC: 11160950. DOI: 10.1167/iovs.65.6.8.


Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care.

Miyagishima K, Qiao F, Stasheff S, Nadal-Nicolas F Vision (Basel). 2024; 8(2).

PMID: 38804352 PMC: 11130890. DOI: 10.3390/vision8020031.


References
1.
Jones D, Kocialkowski S, Liu L, Pearson D, Backlund L, Ichimura K . Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008; 68(21):8673-7. PMC: 2577184. DOI: 10.1158/0008-5472.CAN-08-2097. View

2.
Sugiarto S, Persson A, Gonzalez Munoz E, Waldhuber M, Lamagna C, Andor N . Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011; 20(3):328-40. PMC: 3297490. DOI: 10.1016/j.ccr.2011.08.011. View

3.
Mayes D, Rizvi T, Cancelas J, Kolasinski N, Ciraolo G, Stemmer-Rachamimov A . Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation. Cancer Res. 2011; 71(13):4675-85. PMC: 3464476. DOI: 10.1158/0008-5472.CAN-10-4558. View

4.
Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, Peterson A . Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci. 1996; 16(23):7599-609. PMC: 6579089. View

5.
Alcantara Llaguno S, Chen J, Kwon C, Jackson E, Li Y, Burns D . Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell. 2008; 15(1):45-56. PMC: 2650425. DOI: 10.1016/j.ccr.2008.12.006. View